SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000904454-19-000517
Filing Date
2019-06-21
Accepted
2019-06-21 16:52:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G FOR SYNLOGIC, INC. BY GINKGO BIOWORKS, INC. s13g_061119-synlogic.htm SC 13G 43901
  Complete submission text file 0000904454-19-000517.txt   45469
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Subject) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89131 | Film No.: 19912082
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210 877-422-5362
Ginkgo Bioworks, Inc. (Filed by) CIK: 0001648827 (see all company filings)

IRS No.: 263118890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G